Aprea Therapeutics Inc (APRE)
3.972
+0.05
(+1.32%)
USD |
NASDAQ |
Nov 04, 16:00
4.06
+0.09
(+2.22%)
After-Hours: 20:00
Aprea Therapeutics Price: 3.972 for Nov. 4, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 04, 2024 | 4.03 | 4.03 | 3.835 | 3.972 | 1818.00 |
Nov 01, 2024 | 3.91 | 4.15 | 3.86 | 3.92 | 21184.00 |
Oct 31, 2024 | 3.86 | 4.17 | 3.82 | 3.91 | 14202.00 |
Oct 30, 2024 | 4.34 | 4.42 | 3.92 | 4.01 | 13589.00 |
Oct 29, 2024 | 4.17 | 4.30 | 4.03 | 4.25 | 9038.00 |
Oct 28, 2024 | 3.99 | 4.28 | 3.99 | 4.28 | 25604.00 |
Oct 25, 2024 | 4.05 | 4.15 | 4.05 | 4.08 | 7222.00 |
Oct 24, 2024 | 3.90 | 4.20 | 3.868 | 3.90 | 19485.00 |
Oct 23, 2024 | 4.18 | 4.18 | 3.860 | 3.90 | 19557.00 |
Oct 22, 2024 | 4.35 | 4.35 | 4.00 | 4.18 | 17169.00 |
Oct 21, 2024 | 4.40 | 4.54 | 4.27 | 4.30 | 22898.00 |
Oct 18, 2024 | 5.01 | 5.01 | 4.15 | 4.40 | 86907.00 |
Oct 17, 2024 | 3.76 | 4.45 | 3.60 | 4.45 | 146967.0 |
Oct 16, 2024 | 4.32 | 4.39 | 3.21 | 3.50 | 145700.0 |
Oct 15, 2024 | 2.60 | 3.20 | 2.579 | 3.05 | 55030.00 |
Oct 14, 2024 | 2.62 | 2.62 | 2.51 | 2.56 | 11470.00 |
Oct 11, 2024 | 2.66 | 2.77 | 2.150 | 2.60 | 39497.00 |
Oct 10, 2024 | 2.65 | 2.66 | 2.490 | 2.54 | 5856.00 |
Oct 09, 2024 | 2.51 | 2.59 | 2.150 | 2.56 | 15261.00 |
Oct 08, 2024 | 2.62 | 2.62 | 2.560 | 2.601 | 1682.00 |
Oct 07, 2024 | 2.65 | 2.650 | 2.31 | 2.62 | 255936.0 |
Oct 04, 2024 | 2.68 | 2.69 | 2.60 | 2.60 | 13953.00 |
Oct 03, 2024 | 2.69 | 2.69 | 2.55 | 2.62 | 12115.00 |
Oct 02, 2024 | 2.62 | 2.71 | 2.60 | 2.705 | 14603.00 |
Oct 01, 2024 | 2.71 | 2.800 | 2.540 | 2.60 | 32566.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.54
Minimum
Oct 10 2024
990.60
Maximum
Dec 27 2019
166.44
Average
28.70
Median
Price Benchmarks
Aethlon Medical Inc | 0.3988 |
Brainstorm Cell Therapeutics Inc | 1.80 |
NovaBay Pharmaceuticals Inc | 0.756 |
Palatin Technologies Inc | 1.19 |
iBio Inc | 2.67 |
Price Related Metrics
Price to Book Value | 0.8441 |
Earnings Yield | -76.29% |
Market Cap | 21.57M |